Esperion Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ESPR and other ETFs, options, and stocks.About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets.
CEOSheldon L. Koenig
CEOSheldon L. Koenig
Employees304
Employees304
HeadquartersAnn Arbor, Michigan
HeadquartersAnn Arbor, Michigan
Founded1998
Founded1998
Employees304
Employees304
ESPR Key Statistics
Market cap903.66M
Market cap903.66M
Price-Earnings ratio-7.07
Price-Earnings ratio-7.07
Dividend yield—
Dividend yield—
Average volume7.69M
Average volume7.69M
High today$3.91
High today$3.91
Low today$3.71
Low today$3.71
Open price$3.79
Open price$3.79
Volume4.73M
Volume4.73M
52 Week high$4.03
52 Week high$4.03
52 Week low$0.6925
52 Week low$0.6925
Stock Snapshot
Esperion Therapeutics(ESPR) stock is priced at $3.78, giving the company a market capitalization of 903.66M. It carries a P/E multiple of -7.07.
During the trading session on 2025-12-04, Esperion Therapeutics(ESPR) shares reached a daily high of $3.91 and a low of $3.71. At a current price of $3.78, the stock is +1.9% higher than the low and still -3.3% under the high.
Trading volume for Esperion Therapeutics(ESPR) stock has reached 4.73M, versus its average volume of 7.69M.
Over the past 52 weeks, Esperion Therapeutics(ESPR) stock has traded between a high of $4.03 and a low of $0.69.
Over the past 52 weeks, Esperion Therapeutics(ESPR) stock has traded between a high of $4.03 and a low of $0.69.
Analyst ratings
75%
of 8 ratingsBuy
75%
Hold
12.5%
Sell
12.5%
People also own
Based on the portfolios of people who own ESPR. This list is generated using Robinhood data, and it’s not a recommendation.